Evanston, Illinois
United States
28
2022-07-14
28
2022-12-20
These are the the leading inventors for applications assigned to Aptinyx Inc.:
Aptinyx Inc. based in Evanston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Spiro-lactam NMDA receptor modulators and uses thereof
#2 | 2022-01-06 ✅ Patent 11,512,051 granted on 2022-11-29Spiro-lactam NMDA receptor modulators and uses thereof
#3 | 2021-10-21 ✅ Patent 11,376,250 granted on 2022-07-05Spiro-lactam NMDA receptor modulators and uses thereof
#4 | 2021-02-11 ✅ Patent 11,578,072 granted on 2023-02-14Spiro-lactam NMDA receptor modulators and uses thereof
#5 | 2021-01-07 ✅ Patent 11,427,585 granted on 2022-08-30Spiro-lactam NMDA modulators and methods of using same
#6 | 2020-07-02 ✅ Patent 11,077,094 granted on 2021-08-03Spiro-lactam NMDA receptor modulators and uses thereof
#7 | 2020-06-11 ✅ Patent 11,028,095 granted on 2021-06-08Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof
#8 | 2019-06-27 ✅ Patent 11,370,790 granted on 2022-06-28Spiro-lactam NMDA modulators and methods of using same
#9 | 2019-06-13 ✅ Patent 11,299,495 granted on 2022-04-12Spiro-lactam NMDA receptor modulators and uses thereof
#10 | 2019-06-13 ✅ Patent 10,918,637 granted on 2021-02-16Spiro-lactam NMDA receptor modulators and uses thereof
#11 | 2019-05-30 ✅ Patent 10,961,189 granted on 2021-03-30Spiro-lactam NMDA receptor modulators and uses thereof
#12 | 2018-10-11 ✅ Patent 10,150,769 granted on 2018-12-11Spiro-lactam NMDA modulators and methods of using same
#13 | 2018-09-06 ✅ Patent 10,441,572 granted on 2019-10-15Spiro-lactam NMDA receptor modulators and uses thereof
#14 | 2018-09-06 ✅ Patent 10,441,571 granted on 2019-10-15Spiro-lactam NMDA receptor modulators and uses thereof
#15 | 2018-06-28 ✅ Patent 10,273,239 granted on 2019-04-30Spiro-lactam NMDA receptor modulators and uses thereof
#16 | 2018-06-07 ✅ Patent 10,253,032 granted on 2019-04-09Spiro-lactam NMDA receptor modulators and uses thereof
#17 | 2018-05-10 ✅ Patent 10,316,041 granted on 2019-06-11Spiro-lactam NMDA receptor modulators and uses thereof
#18 | 2018-04-05 ✅ Patent 10,196,401 granted on 2019-02-05Spiro-lactam NMDA receptor modulators and uses thereof
#19 | 2018-04-05 ✅ Patent 10,195,179 granted on 2019-02-05Spiro-lactam NMDA receptor modulators and uses thereof
#20 | 2017-11-23 ✅ Patent 9,932,347 granted on 2018-04-03Spiro-lactam NMDA receptor modulators and uses thereof
#21 | 2017-11-23 ✅ Patent 9,925,169 granted on 2018-03-27Spiro-lactam NMDA receptor modulators and uses thereof
#22 | 2017-08-17 ✅ Patent 10,052,308 granted on 2018-08-21Spiro-lactam NMDA receptor modulators and uses thereof
#23 | 2016-12-22 ✅ Patent 9,579,304 granted on 2017-02-28Spiro-lactam NMDA receptor modulators and uses thereof
#24 | 2016-10-06 ✅ Patent 9,504,670 granted on 2016-11-29Spiro-lactam NMDA receptor modulators and uses thereof
#25 | 2016-05-05 ✅ Patent 9,512,134 granted on 2016-12-06Spiro-lactam NMDA receptor modulators and uses thereof
#26 | 2015-12-31 ✅ Patent 9,738,650 granted on 2017-08-22Spiro-lactam NMDA receptor modulators and uses thereof
#27 | 2015-12-24 ✅ Patent 9,758,525 granted on 2017-09-12Spiro-lactam NMDA receptor modulators and uses thereof
#28 | 2015-12-24 ✅ Patent 9,828,384 granted on 2017-11-28Spiro-lactam NMDA receptor modulators and uses thereof
Also check out Aptinyx Inc.'s (Evanston, United States) applicant profile with 25 patent applications submitted.
150200 ⎘